New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
08:31 EDTBPTHBio-Path Holdings names Ulrich Mueller as COO
Bio-Path Holdings announced that Dr. Ulrich W. Mueller has joined the company as COO. Dr. Mueller will be responsible for the company’s drug development, licensing and intellectual property activities, including managing the company’s clinical trials, pre-clinical and research and development efforts. Mueller was previously a Vice President at the Fred Hutchinson Center Research Center.
News For BPTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 28, 2015
11:11 EDTBPTHBio-Path Holdings granted orphan drug designation for Liposomal Grb-2 in AML
Subscribe for More Information
08:06 EDTBPTHBio-Path granted FDA orphan designation for acute myeloid leukemia treatment
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use